Top

Published in:

01-01-2011 | Original article

Prospective study on the efficacies of fondaparinux and enoxaparin in preventing venous thromboembolism after hip fracture surgery

Authors: Satoshi Sasaki, Naohisa Miyakoshi, Hiroshi Matsuura, Hidetomo Saito, Toru Nakanishi, Yumiko Kudo, Tomiko Fujiya, Yoichi Shimada

Published in: Journal of Orthopaedic Science | Issue 1/2011

Abstract

Background

Venous thromboembolism (VTE) is a common complication in hip fracture surgery (HFS). Fondaparinux (FPX) and enoxaparin (ENO) have been reported to decrease the incidence of VTE after HFS. The purpose of this study was to determine the efficacies of FPX and ENO and the superior agent for preventing VTE after HFS by performing a prospective study in a Japanese population.

Methods

Eighty-four Japanese patients who underwent HFS were assigned to either FPX (received FPX 1.5 or 2.5 mg/day for 14 days), ENO (received ENO 2000 IU once or twice/day for 14 days), or untreated control (CTRL) groups in order of surgery. All patients underwent ultrasonography of the lower extremities 7 days after HFS to evaluate the extent of deep-vein thrombosis. Incidence of VTE, D-dimer values measured at admission and 7 and 14 days after HFS, and the side effects of FPX and ENO were compared.

Results

The incidence of VTE and the D-dimer values on days 7 and 14 in the FPX group were significantly lower than the corresponding levels in the CTRL group (P < 0.05). The D-dimer values on day 7 in the ENO group were significantly lower than those in the CTRL group, whereas the incidence of VTE was not significantly different. Side effects were observed in 3 cases: major bleeding occurred in 2 patients who received FPX, whereas minor bleeding occurred in 1 patient who received ENO.

Conclusions

We concluded that FPX was the superior agent for preventing VTE after HFS. However, patients receiving FPX should be monitored for bleeding.

Geerts WH, Bergquist D, Pineo GF, Heit JA, Samama CF, Lassen MR, Colwell CW. Prevention of venous thromboembolism. American College of Chest Physicians evidence-based clinical guidelines (8th edition). Chest. 2008;133:381S–453S.

Eriksson BI, Bauer KA, Lassen MR, Turpie AGG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med. 2001;345:1298–304.PubMedCrossRef

Eriksson BI, Lassen MR. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery. A multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2003;163:1337–42.PubMedCrossRef

Bauer KA, Eriksson BI, Lassen MR, Turpie AGG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med. 2001;345:1305–10.PubMedCrossRef

Lassen MR, Bauer KA, Eriksson BI, Turpie AGG. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet. 2002;359:1715–20.PubMedCrossRef

Turpie AGG, Bauer KA, Eriksson BI, Lassen MR. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet. 2002;359:1721–6.PubMedCrossRef

Fuji T, Fujita S. Efficacy and safety of fondaparinux sodium for the prevention of venous thromboembolism after hip-fracture surgery. Kossetsu (Fracture). 2008;30:206–9 (in Japanese).

Fuji T, Fujita S. Efficacy and safety of enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. Hip Joint. 2008;34:679–82 (in Japanese).

Sasaki S, Miyakoshi N, Matsuura H, Saitoh H, Kudoh D, Shimada Y. Prospective randomized controlled trial on the effect of fondaparinux sodium for the prevention of venous thromboembolism after hip fracture surgery. J Orthop Sci. 2009;14:491–6.PubMedCrossRef

10.

Bongard O, Wicky J, Peter R, Simonovska S, Vogel JJ, Moerloose P, Bounameaux H. D-dimer plasma measurement in patients undergoing major hip surgery: use in the prediction and diagnosis of postoperative proximal vein thrombosis. Thromb Res. 1994;74:487–93.PubMedCrossRef

11.

Peetz D, Hafner G, Hansen M, Mayer A, Rippin G, Rommens PM, Prellwitz W. Dose-adjusted thrombosis prophylaxis in trauma surgery according to levels of D-dimer. Thromb Res. 2000;98:473–83.PubMedCrossRef

12.

Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.PubMedCrossRef

13.

Turpie AGG, Gallus AS, Hoek JA. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med. 2001;344:619–25.PubMedCrossRef

14.

Hirsh J, Levine MN. Low molecular weight heparin. Blood. 1992;79:1–17.PubMed

15.

Turpie AGG, Levine MN, Hirsh J, Carter CJ, Jay RM, Powers PJ, Andrew M, Hull RD, Gent M. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med. 1986;315:925–9.PubMedCrossRef

16.

Barsotti J, Gruel Y, Rosset P, Favard L, Dabo B, Andreu J, Delahousse B, Leroy J. Comparative double-blind study of two dosage regimens of low-molecular weight heparin in elderly patients with a fracture of the neck of the femur. J Orthop Trauma. 1990;4:371–5.PubMed

17.

Thaler HW, Roller RE, Greiner N, Sim E, Korninger C. Thromboprophylaxis with 60 mg enoxaparin is safe in hip trauma surgery. J Trauma. 2001;51:518–21.PubMedCrossRef

18.

Kim T, Murakami T, Hori M, Kumano S, Sakon M, Nakamura H. Efficacy of multi-slice helical CT venography for the diagnosis of deep vein thrombosis: comparison with venous sonography. Radiat Med. 2004;22:77–81.PubMed

19.

Lensing AWA, Prandoni P, Büller HR, Casara D, Cogo A, Cate JWT. Lower extremity venography with iohexol: results and complications. Radiology. 1990;177:503–5.PubMed

20.

Pedersen OM, Aslaksen A, Vik-Mo H, Bassoe AM. Compression ultrasonography in hospitalized patients with suspected deep venous thrombosis. Arch Intern Med. 1991;151:2217–20.PubMedCrossRef

21.

Shiota N, Satoh T, Matsuo M, Kajiya M, Sakata K, Inoue H. A study of postoperative deep-vein thrombosis in proximal femoral fracture. Rinsho Seikeigeka (Clin Orthop Surg). 2003;38:593–9 (in Japanese).

22.

Quinlan DJ, Alikhan RA, Gishen P, Sidhu PS. Variations in lower limb venous anatomy: implications for US diagnosis of deep vein thrombosis. Radiology. 2003;228:443–8.PubMedCrossRef

23.

Perrier A, Desmarais S, Miron MJ, Moerloose P, Lepage R, Slosman D, Didier D, Unger PF, Patenaude JV, Bounameaux H. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet. 1999;353:190–5.PubMedCrossRef

24.

Fuji T, Ochi T, Niwa S, Fujita S. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin. J Orthop Sci. 2008;13:442–51.PubMedCrossRef

Title: Prospective study on the efficacies of fondaparinux and enoxaparin in preventing venous thromboembolism after hip fracture surgery
Authors: Satoshi Sasaki
Naohisa Miyakoshi
Hiroshi Matsuura
Hidetomo Saito
Toru Nakanishi
Yumiko Kudo
Tomiko Fujiya
Yoichi Shimada
Publication date: 01-01-2011
Publisher: Springer Japan
Published in: Journal of Orthopaedic Science / Issue 1/2011
Print ISSN: 0949-2658
Electronic ISSN: 1436-2023
DOI: https://doi.org/10.1007/s00776-010-0011-5

At a glance: The STEP trials

Springer Medicine

Prospective study on the efficacies of fondaparinux and enoxaparin in preventing venous thromboembolism after hip fracture surgery

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2011

Course of NTX changes under continuous bisphosphonate treatment in cases of NTX over-reduction due to long-term treatment with bisphosphonates

Modular neck prostheses in DDH patients: 11-year results

Enhancing the antibacterial activity of biomimetic HA coatings by incorporation of norvancomycin

Hemicallotasis for correction of varus deformity of the proximal tibia using a unilateral external fixator

Factors associated with radiographic osteoarthritis of the knee among community-dwelling Japanese women: the Hizen-Oshima Study

Squeaking sound in total hip arthroplasty using ceramic-on-ceramic bearing surfaces